Buscar (Noticias)

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial - Slideshow

business

2026-03-17. The following slide deck was published by Rhythm Pharmaceuticals, Inc.
2026-03-17 06:31:12